Supplemental
. Percentage distribution of protein isoforms following the treatment of HepG2 cells with copaiba essential oil. (a-c) Consistent increases of phosphor-isoforms of pMEK1 (a), pppMEK2 (b), and pERK1/2 (c) indicated an up-regulation of the MAPK signaling pathway. MEK1: unphosphorylated isoform; pMEK1: phosphorylated isoforms with pI values from 5.76 to 5.25; ppMEK2: MEK2 phosphor-isoform at pI 5.63; pppMEK2: MEK2 phosphor-isoforms with pI values from 5.44 to 5.29; ERK2: unphosphorylated ERK2 isoform with pI 6.63; pERK1/2: all phosphor-isoforms of ERK1 and ERK2. (d,e) Consistent decreases of ppAkt (d) and pp4EBP1 (e) phosphor-isoforms indicated a down-regulation of the PI3K/AKT/mTOR signaling pathway. pAkt: phosphor-isoforms of Akt with pI values from 5.65-5.15; ppAkt: phosphor-isoforms of Akt with pI values from 5.15-5.05. 4EBP1: unphosphorylated 4EBP1 isoform with pI 5.21; p4EBP1: phosphor-isoform of 4EBP1 with pI 5.06; pp4EBP1: phosphorisoforms of 4EBP1 with pI values from 4.99 -4.60. (f) An increase in ppSTAT3 phosphor-isoforms indicated an upregulation of the JAK/STAT signaling pathway. pSTAT3: phosphor-isoform of STAT3 with pI 5.69; ppSTAT3: phosphorisoforms of STAT3 with pI 5. 65-5.20 . Error bars are standard deviations across six repeated measurements. Asterisks indicate statistical significance with p-value <0.01 against untreated control. p-value was calculated using the paired Student's t-test. CD1 was used for these assessments. 
